A diabetic self-injecting insulin using a novopen. This pen-like dispenser, unlike a hypodermic syringe, contains insulin in portable cartridges, and it meters the required dose. Here, the insulin being injected subcutaneously into the leg of a male diabetic, is Human Actrapid insulin. It is taken before each meal (2, 4 or 6 units, depending on size of meal). It is a supplementary dose, to add to the insulin the patient takes before going to bed each night. Diabetes mellitus sufferers cannot absorb glucose in the blood due to a lack of this insulin hormone. They are reliant on injections: Human Actrapid insulin is manufactured synthetically by genetic engineering.
Model release not required. Property release not required.